IMAC Holdings, Inc. (BACK)
OTCMKTS · Delayed Price · Currency is USD
0.0710
0.00 (0.00%)
Aug 15, 2025, 2:17 PM EDT
IMAC Holdings Market Cap
IMAC Holdings has a market cap or net worth of $268.73 thousand as of August 15, 2025. Its market cap has decreased by -91.03% in one year.
Market Cap
268.73K
Enterprise Value
2.15M
Revenue
57.80K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since February 13, 2019, IMAC Holdings's market cap has decreased from 26.65M to 268.73K, a decrease of -98.99%. That is a compound annual growth rate of -50.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 268.73K | -89.49% |
| Dec 31, 2024 | 2.56M | 1.63% |
| Dec 29, 2023 | 2.52M | -61.20% |
| Dec 30, 2022 | 6.48M | -78.30% |
| Dec 31, 2021 | 29.88M | 64.93% |
| Dec 31, 2020 | 18.12M | 41.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 606.72M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 389.51M |
| Northwest Biotherapeutics | 351.78M |
| CytoDyn | 336.73M |